EF
CRL icon

Empowered Funds’s Charles River Laboratories CRL Stock Holding History

Empowered Funds’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,445
Closed -$533K – 558
2022
Q4 		$533K Buy
+2,445
New +$534K 0.03% 349

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Empowered Funds's CRL Position: Q1 2026 in Review

Empowered Funds opened a new position in Charles River Laboratories (CRL) in Q1 2026: 3,137 shares worth $541K. The stake represents ﹤0.01% of the portfolio and ranks #1623 among its holdings. This is a return to the name: Empowered Funds previously reported a position in CRL as recently as Q3 2025.

Empowered Funds first reported a position in CRL in Q4 2017 and has held it in 13 quarters since. The position peaked at $1.84M in Q4 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Empowered Funds held 3,137 shares of Charles River Laboratories worth $541K as of Q1 2026.
  • Charles River Laboratories was a new Empowered Funds position in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of Empowered Funds's portfolio in Q1 2026, its #1623 holding.
  • Empowered Funds first reported a position in Charles River Laboratories in Q4 2017 and has held it in 13 quarters since.
  • Empowered Funds's Charles River Laboratories position peaked at $1.84M in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.